At Washington Patent Panel, Academia and Private Sector Duke It Out | GenomeWeb

WASHINGTON, Sept. 24 - At a consumer-oriented panel discussion about the merits of gene-related patents, two salient points managed to bubble to the surface: Academic types and corporate folks may agree that patents are the linchpins of innovation, but they disagree over what R&D stage a patent should be awarded.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The final text of the bill to reauthorize the America COMPETES Act might smooth over the differences between NSF and the House science committee, ScienceInsider says.

Four Republican lawmakers urge President-elect Donald Trump to keep Francis Collins as NIH director, Stat News reports.

In Genome Research this week: Platinum variant catalog, algorithmic strategy for upgrading fragmented assemblies, and more.

Sequencing of a 10,000-year-old mummy leads to its repatriation to the Fallon Paiute-Shoshone Tribe, Nature News reports.